France has confirmed it will dramatically reduce its financial contribution to the global fight against HIV/AIDS, a decision that is already drawing fierce criticism from public health organizations and political leaders. The cuts will push France from the world’s second-largest contributor to fifth place, marking a sharp reversal from the leadership role it once claimed in global health efforts.
The French government confirmed that between 2026 and 2028 it plans to contribute €860 million combined to the Global Fund and Unitaid, two of the world’s main organizations financing the fight against HIV/AIDS, tuberculosis, and malaria.
That figure represents a reduction of more than half of France’s previous commitment. During the last funding cycle from 2023 to 2025, France pledged €1.6 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria alone, plus an additional €255 million to Unitaid.
The decision confirms earlier reports revealed in February and effectively ends hopes that Paris might reverse course ahead of the upcoming One Health Summit, which President Emmanuel Macron is scheduled to open in Lyon.
Government cites strained public finances
Officials say the decision is driven by France’s deteriorating public finances.
According to the Ministry of Foreign Affairs, the government is attempting to reduce the national deficit to 5% of GDP by 2026, forcing significant spending cuts across multiple sectors.
“Public finances are currently under considerable pressure,” the ministry said in a statement. Despite the cuts, it insisted that global health remains a priority area of France’s international solidarity policy.
Critics, however, say the numbers tell a different story.
NGOs warn of devastating consequences
Nine HIV/AIDS organizations condemned the move in a joint statement, calling it a dangerous retreat from global health leadership.
“France is abandoning millions of people,” said Camille Spire, president of the French HIV advocacy group AIDES.
“This is the largest reduction among all G7 countries,” added Florence Thune, head of Sidaction. “France is effectively deserting the global fight against pandemics.”
The cuts will have immediate geopolitical implications as well. France’s reduced commitment now places it behind the United States, Germany, and the United Kingdom, and even behind the philanthropic funding of the Bill & Melinda Gates Foundation, which pledged €788 million.
Political backlash in France
The decision is also facing criticism inside France’s parliament.
On February 3, the National Assembly of France unanimously passed a resolution calling on the government to maintain strong financial support in the global fight against HIV/AIDS.
The measure, introduced by Socialist MP Arthur Delaporte, passed with all 135 votes in favor, though it is not legally binding.
Delaporte urged the government to reconsider the cuts, warning that France risks abandoning its long-standing international role in global health.
“The government is choosing to follow the same unfortunate path as Donald Trump,” he said.
His comment refers to the recent reduction in U.S. funding for global HIV programs. Since Trump returned to the White House, the United States — historically the world’s largest contributor — has reportedly reduced its global HIV/AIDS funding from $6 billion to $4.6 billion.
From global leader to lagging contributor
Public health experts say the symbolism of France’s decision may be as damaging as the financial impact.
For years, France positioned itself as one of the key champions of global HIV/AIDS programs. That reputation was cemented in 2019 when France hosted a major replenishment conference for the Global Fund to Fight AIDS, Tuberculosis and Malaria in Lyon.
At the time, President Emmanuel Macron delivered a passionate speech urging world leaders to intensify their efforts.
“The goal of ending the epidemic by 2030 is achievable,” he said then. “But only if we live up to our responsibilities today.”
Many activists now say those words ring hollow.
The 2030 goal slipping out of reach
Advocacy groups warn that the combination of reduced funding from both the United States and France could derail global efforts to eliminate HIV/AIDS as a public health threat by 2030.
“Who can still believe the epidemic will end by 2030?” asked the French advocacy group Actions Traitements.
“What once seemed achievable just a few years ago is quickly becoming impossible.”
The Global Fund to Fight AIDS, Tuberculosis and Malaria had hoped to raise $18 billion for its next three-year funding cycle, but current pledges suggest the total may fall below $13 billion — a shortfall that could directly impact treatment, prevention programs, and lifesaving medication in many parts of the world.
For critics, the concern is simple: when major donors pull back, the consequences are measured not just in budgets — but in lives.
No comments:
Post a Comment